SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Journal of Renin-Angiotensin-Aldosterone System
This Article
Right arrow Free Full Text (Free PDF) Free
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Poulter, N.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Poulter, N.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Are current therapies for hypertension achieving their goal?

Neil Poulter

International Centre for Circulatory Health, National Heart and Lung Institute, Imperial College London, London, UK, n.poulter{at}imperial.ac.uk

The majority of adults with hypertension do not get their blood pressures controlled to currently recommended targets, despite relatively consistent blood pressure targets in guidelines from around the world. This requires major preventative and treatment strategies to be implemented both in the general population and in the hypertensive population. The reasons behind the failure to achieve blood pressure targets are many and varied and include physician inertia, ineffective drugs, poor patient compliance, side-effects and poor communication of guidelines. Physician inertia is perhaps the most important contributor to under-treatment. The recent A/CD algorithm in guidelines co-produced by the British Hypertension Society and the National Institute for Health and Clinical Excellence in the UK and Ireland provide a memorable, pragmatic and logical approach to guide drug sequencing with a view to achieving blood pressure targets for most patients.

Key Words: antihypertensive agents • blood pressure control

Journal of Renin-Angiotensin-Aldosterone System, Vol. 7, No. 2 suppl, S3-S6 (2006)
DOI: 10.3317/jraas.2006.034


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




Advertisement